Medication info
Croviget Tablet 10/20 Milligrams

Croviget Tablet 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to nearly white round film-coated tablet
Packaging
30 tablets (15 tablets/blister × 2)
Approval status
Active

MFDS item code 201606052 · Approved 2016.10.12 · Insurance code 671806340

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before starting and while taking this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • decreased HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication helps reduce elevated total cholesterol, LDL cholesterol, apo B protein, triglyceride, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial, as well as mixed dyslipidemia, and increases HDL cholesterol. It is primarily used as an adjunct to dietary therapy, and it is important to implement it alongside appropriate dietary management that includes restriction of saturated fats and cholesterol. Additionally, when administering lipid-regulating medications to patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia, various risk factors must be considered. Before administration, check for secondary causes such as diabetes, hypothyroidism, and chronic kidney disease, and treat if necessary. During treatment, total cholesterol, LDL, HDL, and triglycerides should be continuously monitored and managed. This medication is used for improving dyslipidemia and reducing the risk of atherosclerotic vascular disease.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients must continue to follow a standard cholesterol-lowering diet before starting and while taking this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may rarely cause rhabdomyolysis, which can lead to serious muscle damage. Particularly, patients with acute infections, hypotension, major surgery or trauma, serious metabolic and endocrine disorders should temporarily discontinue or stop using this medication. Patients with allergies to the main ingredient or components of this medication, severely impaired liver function, muscle disease, certain renal impairment, pregnant or breastfeeding women should not take this medication. Furthermore, patients at high risk for myopathy, such as those with moderately impaired renal function, hypothyroid patients, family history of muscle disease, alcoholics, and those taking certain concomitant medications should use this medication with caution. This medication may affect liver function, so regular liver function tests should be performed before and during treatment. Symptoms such as muscle pain, weakness, fatigue, fever should be reported to medical personnel immediately, and blood tests may be required to check for muscle damage if necessary. This medication may interact with other drugs, so it is important to inform medical personnel of all medications being taken, especially when combined with anticoagulants, fibrates, certain antibiotics, antifungals, etc. Women who are pregnant or may become pregnant should use an appropriate method of contraception during treatment with this medication, and it should be discontinued immediately if pregnancy is confirmed. Breastfeeding women should also avoid taking this medication. The safety and efficacy of this medication in children and adolescents have not been sufficiently established, so it is not recommended for this age group. Elderly patients or those with impaired renal and hepatic function should be more cautious when taking this medication, and dose adjustment may be necessary. There is no specific antidote for overdose, so treatment should be symptomatic and involve testing for liver function and muscle damage. This medication should be kept out of reach of children and it is advisable not to transfer it to another container. Dizziness or headaches may occur during treatment, so caution should be taken when driving or operating machinery.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, myalgia, edema, elevated bilirubin levels, acneiform dermatitis, pruritus, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, dizziness, upper respiratory infection, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia and systemic symptoms associated with drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, dizziness, elevated ALT, chest pain, cough, myalgia, increased CK, constipation, elevated AST, weakness, joint pain, fatigue, numbness, paresthesia, chest discomfort, nausea, diarrhea, loss of appetite, abdominal distension, abnormal liver function tests, syncope, systemic pain, muscle cramping, gout, erectile dysfunction, chest pain, facial edema, strange sensations, drug intolerance, colorectal polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heartbeat, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to nearly white round film-coated tablet

Package unit

30 tablets (15 tablets/blister × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.